A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin

International Journal of Dermatology

Volumn 43, Issue 8, 2004, Pages 597-599

  Adachi, Atsuko ^a,b   Fukunaga, Atsushi ^a,b   Horikawa, Tatsuya ^a,b  

^a Hyogo Prefectural Kakogawa Hospital   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIPHASIC INSULIN; HISTAMINE; HUMULIN U; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN; METHYL PARABEN; PENFILL 30R; PENFILL N; PENFILL R; PHENOL; PROTAMINE SULFATE; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG; ZINC CHLORIDE;

AGED; ANTIBODY SPECIFICITY; ARTICLE; BASOPHIL; CASE REPORT; CELL STIMULATION; DIABETES MELLITUS; DYSPNEA; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION; INSULIN ALLERGY; LABORATORY TEST; POLLEN ALLERGY; PRURITUS; SKIN TEST; SYMPTOMATOLOGY; URTICARIA;

AGED; DIABETES MELLITUS; DRUG ERUPTIONS; FEMALE; HISTAMINE RELEASE; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOGLOBULIN E; INSULIN; INSULIN, LONG-ACTING; INTRADERMAL TESTS; URTICARIA;

EID: 4444225626     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02141.x     Document Type: Article

References (14)

1. Lamkin N, Liegerman P, Hashimoto K, et al. Allergic reactions to insulin. J Allergy Clin Immunol 1976; 58: 213-223.
2. Takatsuki H, Ishii H, Yamauchi T, et al. A case of insulin allergy: the crystalline human insulin may mask its antigenicity. Diabetes Res Clin Prac 1991; 12: 137-139.
3. Itoh M, Uchimura K, Makino M, et al. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care 1999; 22: 1221-1224.
4. Nishii H, Nishimura S, Higashiura M, et al. A new method for histamine release from purified peripheral blood basophils using monoclonal antibody-coated magnetic beads. J Immunol Method 2000; 240: 39-46.
5. Feinglos MN, Jegasothy BV. Insulin allergy due to zinc. Lancet 1979: 22-24.
6. Dykewicz MS, Kim HW, Orfan N, et al. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin. J Allergy Clin Immunol 1994; 93: 117-125.
7. Bentley G, Dodson E, Dodson G, et al.. Structure of insulin in 4-zinc insulin. Nature 1976; 261: 166-168.
8. Robbins DC, Cooper SM, Fineberg SE, et al. Antibodies to covalent aggregates of insulin in blood of insulin-using diabetic patients. Diabetes 1987; 36: 838-841.
9. Ratner RE, Phillips TM, Steiner M. Persistant cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes 1990; 39: 728-733.
10. Kang S, Brange J, Burch A, et al. Subcutaneous insulin absorption explained by insulin's phycochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans. Diabetes Care 1991; 14: 942-948.
11. Kumar D. Lispro analog for treatment of generalized allergy to human insulin. Diabetes Care 1997; 20: 1357-1359.
12. Airaghi L, Lorini M, Tedeschi A. The insulin analog aspart: a safe alternative insulin allergy. Diabetes Care 2001; 24: 2000.
13. B32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes. Diabetes Care 2001; 24: 411-412.
14. Grammer LC, Roberto M, Buchanan TA, et al. Specifity of immunoglobulin E and immunoglobulin G against human (recombinant DNA) insulin in human insulin allergy and resistance. J Lat Clin Med 1987; 109: 141-146.